Description
Get Access to Nitisinone for Capsules in India
Orfadin (nitisinone) is a hydroxy-phenylpyruvate dioxygenase inhibitor used to treat hereditary tyrosinemia type 1 (HT-1) in both adults and children. This medication works by blocking the enzyme that causes a buildup of harmful substances in the body. Orfadin is typically prescribed alongside a special diet that restricts the intake of tyrosine and phenylalanine, essential amino acids, to manage the condition effectively. By reducing the levels of toxic substances, Orfadin helps prevent liver and kidney damage associated with HT-1, improving the quality of life for patients with this rare genetic disorder.
Recommended Dosage:
- Starting Dosage: The recommended starting dosage of Orfadin is 0.5 mg/kg, administered orally twice a day.
- Maintenance Regimen: For patients aged 5 years and older who achieve undetectable levels of serum and urine succinylacetone after at least 4 weeks on a stable nitisinone dosage, the total daily dose of Orfadin may be administered once daily (e.g., 1 to 2 mg/kg once a day).





